Pluronic® block copolymers:: novel functional molecules for gene therapy

被引:305
作者
Kabanov, AV [1 ]
Lemieux, P
Vinogradov, S
Alakhov, V
机构
[1] Univ Nebraska, Nebraska Med Ctr 986025, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Supratek Pharma Inc, Laval, PQ H7B 1B7, Canada
基金
美国国家科学基金会;
关键词
gene delivery; gene therapy; DNA; polycation; block copolymer; poly(ethylene glycol);
D O I
10.1016/S0169-409X(02)00018-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pluronic(R) block copolymers are recognized pharmaceutical excipients listed in the US and British Pharmacopoeia. They have been used extensively in a variety of pharmaceutical formulations including delivery of low molecular mass drugs and polypeptides. This review describes novel applications of Pluronic block copolymers in gene therapy. In particular, these molecules can modify the biological response during gene therapy in the skeletal muscle, resulting in an enhancement of the transgene expression as well as an enhancement of the therapeutic effect of the transgene. Furthermore, Pluronic(R) block copolymers are versatile molecules that can be used as structural elements of the polycation-based gene delivery systems (polyplexes). Based on these studies, the use of block copolymers in gene delivery is a promising area of research, in which new and important developments are expected. (C) 2002 Elsevier Science B V All rights reserved.
引用
收藏
页码:223 / 233
页数:11
相关论文
共 77 条
[1]   An amorphous hydrogel enhances epithelialisation of wounds [J].
Ågren, MS .
ACTA DERMATO-VENEREOLOGICA, 1998, 78 (02) :119-122
[2]   Block copolymeric biotransport carriers as versatile vehicles for drug delivery [J].
Alakhov, V ;
Klinski, E ;
Lemieux, P ;
Pietrzynski, G ;
Kabanov, A .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (04) :583-602
[3]   Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials [J].
Alakhov, V ;
Klinski, E ;
Li, SM ;
Pietrzynski, G ;
Venne, A ;
Batrakova, E ;
Bronitch, T ;
Kabanov, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :113-134
[4]  
Alakhov V Y, 1998, Expert Opin Investig Drugs, V7, P1453, DOI 10.1517/13543784.7.9.1453
[5]   Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer [J].
Alakhov, VY ;
Moskaleva, EY ;
Batrakova, EV ;
Kabanov, AV .
BIOCONJUGATE CHEMISTRY, 1996, 7 (02) :209-216
[6]  
Allison A C, 1990, Semin Immunol, V2, P369
[7]   AN ADJUVANT FORMULATION THAT SELECTIVELY ELICITS THE FORMATION OF ANTIBODIES OF PROTECTIVE ISOTYPES AND OF CELL-MEDIATED-IMMUNITY [J].
ALLISON, AC ;
BYARS, NE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (02) :157-168
[8]   Enhancement of the polycation-mediated DNA uptake and cell transfection with pluronic P85 block copolymer [J].
Astafieva, I ;
Maksimova, I ;
Lukanidin, E ;
Alakhov, V ;
Kabanov, A .
FEBS LETTERS, 1996, 389 (03) :278-280
[9]   Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells [J].
Batrakova, E ;
Lee, S ;
Li, S ;
Venne, A ;
Alakhov, V ;
Kabanov, A .
PHARMACEUTICAL RESEARCH, 1999, 16 (09) :1373-1379
[10]   Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity [J].
Batrakova, EV ;
Dorodnych, TY ;
Klinskii, EY ;
Kliushnenkova, EN ;
Shemchukova, OB ;
Goncharova, ON ;
Arjakov, SA ;
Alakhov, VY ;
Kabanov, AV .
BRITISH JOURNAL OF CANCER, 1996, 74 (10) :1545-1552